Nanobiotix (EPA: NANO) revenue
Nanobiotix reported revenue of €29.6m for fiscal 2025; in fiscal 2024 it was −€11.6m. Since fiscal 2020 its revenue has grown by 1,080.1%, an average growth of 63.8% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | €29.6m | — | −€10.8m | −36.5% |
| 2024 | −€11.6m | −138.6% | −€68.4m | — |
| 2023 | €30.1m | +529.4% | −€26.8m | −89.1% |
| 2022 | €4.8m | +80.4% | −€46.7m | −977.8% |
| 2021 | €2.6m | +5.4% | −€52.6m | −1,986.4% |
| 2020 | €2.5m | — | −€36.4m | −1,450.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of euros, except per-share amounts.
Questions about the revenue of Nanobiotix
- How much revenue did Nanobiotix make in fiscal 2025?
- Nanobiotix reported revenue of €29.6m for fiscal 2025, compared with −€11.6m in fiscal 2024.
- How much has the revenue of Nanobiotix grown?
- Between fiscal 2020 and fiscal 2025 it went from €2.5m to €29.6m: 1,080.1% more, an average growth of 63.8% a year.
- What was the best year for revenue at Nanobiotix?
- Of its last 6 fiscal years, fiscal 2023, with €30.1m.
- Where do the figures for Nanobiotix come from?
- From the report Nanobiotix files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Nanobiotix files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Nanobiotix: the Nanobiotix page · annual accounts · net income.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.